|
|
Previous Article | Table of Contents | Next Article 
Interleukin-4 receptor regulation in human monocytic cells
H de Wit, DW Hendriks, MR Halie and E Vellenga
Department of Internal Medicine, University of Groningen, The Netherlands.
The regulation of the interleukin-4 receptor (IL-4R) was studied at mRNA
and protein level in monocytic cells on stimulation with activators of
different intracellular signaling pathways and IL-4. Activation of protein
kinase C-dependent pathways with phorbol myristate acetate (PMA) or
activation of protein kinase A-dependent pathways with DBcAMP and
prostaglandin E2 resulted in an augmented IL- 4R expression at mRNA and
protein level. Transcriptional and posttranscriptional mechanisms seemed to
be involved in the promotive effect of DBcAMP because the transcription
rate increased 1.8-fold, and the half-life of IL-4R mRNA was prolonged to
150 minutes compared with 120 minutes in unstimulated cells. In contrast,
the effect of PMA could only be ascribed to changes at transcriptional
level. However, activation of Ca(2+)-dependent pathways with A23187 or
stimulation with IL-4 had no effect on the IL-4R expression. The
unresponsiveness to IL- 4 could not be ascribed to a nonfunctional receptor
because IL-4 did modulate the CD14, CD23, and HLA-DR antigen expression.
These results are in contrast with IL-4R regulation in T cells, which is
affected by IL-4- and Ca(2+)-dependent pathways. The discrepancy might be
caused by the presence of the common IL-2 receptor gamma chain (gamma c) in
T cells and the absence of the gamma c in monocytic cells, as has been
shown by polymerase chain reaction. These data indicate that IL-4Rs are
differentially regulated, depending on the cell type studied.
Volume 84,
Issue 2,
pp. 608-615,
07/15/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Yamada, F. Sheikh, T. Niimi, F. J. DeMayo, A. D. Keegan, R. P. Donnelly, and S. Kimura
Induction of Uteroglobin-Related Protein 2 (Ugrp2) Gene Expression by the Th2 Cytokines IL-4 and IL-13
J. Immunol.,
November 1, 2005;
175(9):
5708 - 5715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-Y. So, H.-H. Park, and C.-E. Lee
IFN-{gamma} and IFN-{alpha} Posttranscriptionally Down-Regulate the IL-4-Induced IL-4 Receptor Gene Expression
J. Immunol.,
November 15, 2000;
165(10):
5472 - 5479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Roy and M. K. Cathcart
Induction of 15-Lipoxygenase Expression by IL-13 Requires Tyrosine Phosphorylation of Jak2 and Tyk2 in Human Monocytes
J. Biol. Chem.,
November 27, 1998;
273(48):
32023 - 32029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Bonder, H. L. Dickensheets, J. J. Finlay-Jones, R. P. Donnelly, and P. H. Hart
Involvement of the IL-2 Receptor {gamma}-Chain ({gamma}c) in the Control by IL-4 of Human Monocyte and Macrophage Proinflammatory Mediator Production
J. Immunol.,
April 15, 1998;
160(8):
4048 - 4056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Lugli, N. Feng, M. H. Heim, M. Adam, B. Schnyder, H. Etter, M. Yamage, H.-P. Eugster, R. A. Lutz, G. Zurawski, et al.
Tumor Necrosis Factor alpha Enhances the Expression of the Interleukin (IL)-4 Receptor alpha -Chain on Endothelial Cells Increasing IL-4 or IL-13-induced Stat6 Activation
J. Biol. Chem.,
February 28, 1997;
272(9):
5487 - 5494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kotanides and N. C. Reich
Interleukin-4-induced STAT6 Recognizes and Activates a Target Site in the Promoter of the Interleukin-4 Receptor Gene
J. Biol. Chem.,
October 11, 1996;
271(41):
25555 - 25561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. I. Obiri, W. Debinski, W. J. Leonard, and R. K. Puri
Receptor for Interleukin 13
J. Biol. Chem.,
April 14, 1995;
270(15):
8797 - 8804.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|